BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24066726)

  • 1. Quantitative prediction of renal transporter-mediated clinical drug-drug interactions.
    Feng B; Hurst S; Lu Y; Varma MV; Rotter CJ; El-Kattan A; Lockwood P; Corrigan B
    Mol Pharm; 2013 Nov; 10(11):4207-15. PubMed ID: 24066726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and Quantitative Prediction of Renal Transporter-Mediated Drug-Drug Interactions.
    Feng B; Varma MV
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S110-21. PubMed ID: 27385169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the monkey an appropriate animal model to examine drug-drug interactions involving renal clearance? Effect of probenecid on the renal elimination of H2 receptor antagonists.
    Tahara H; Kusuhara H; Chida M; Fuse E; Sugiyama Y
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1187-94. PubMed ID: 16291876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of renal transporter-mediated drug-drug interactions for a drug which is an OAT substrate and inhibitor using PBPK modelling.
    Ball K; Jamier T; Parmentier Y; Denizot C; Mallier A; Chenel M
    Eur J Pharm Sci; 2017 Aug; 106():122-132. PubMed ID: 28552429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organic anion and cation transporters are possibly involved in renal excretion of entecavir in rats.
    Yanxiao C; Ruijuan X; Jin Y; Lei C; Qian W; Xuefen Y; Hong T; Xueying Z; Davey AK; Jiping W
    Life Sci; 2011 Jul; 89(1-2):1-6. PubMed ID: 21466809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of renal transporter mediated drug-drug interactions for pemetrexed using physiologically based pharmacokinetic modeling.
    Posada MM; Bacon JA; Schneck KB; Tirona RG; Kim RB; Higgins JW; Pak YA; Hall SD; Hillgren KM
    Drug Metab Dispos; 2015 Mar; 43(3):325-34. PubMed ID: 25504564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic in vitro studies confirm that inhibition of the renal apical efflux transporter multidrug and toxin extrusion (MATE) 1, and not altered absorption, underlies the increased metformin exposure observed in clinical interactions with cimetidine, trimethoprim or pyrimethamine.
    Elsby R; Chidlaw S; Outteridge S; Pickering S; Radcliffe A; Sullivan R; Jones H; Butler P
    Pharmacol Res Perspect; 2017 Oct; 5(5):. PubMed ID: 28971610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery.
    Feng B; Varma MV; Costales C; Zhang H; Tremaine L
    Expert Opin Drug Discov; 2014 Aug; 9(8):873-90. PubMed ID: 24857286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron Emission Tomography-Based Pharmacokinetic Analysis To Assess Renal Transporter-Mediated Drug-Drug Interactions of Antimicrobial Drugs.
    Hernández-Lozano I; Mairinger S; Filip T; Löbsch M; Stanek J; Kuntner C; Bauer M; Zeitlinger M; Hacker M; Helbich TH; Wanek T; Langer O
    Antimicrob Agents Chemother; 2023 Mar; 67(3):e0149322. PubMed ID: 36786609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics.
    Yasui-Furukori N; Uno T; Sugawara K; Tateishi T
    Clin Pharmacol Ther; 2005 Jan; 77(1):17-23. PubMed ID: 15637527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactions.
    Greupink R; Schreurs M; Benne MS; Huisman MT; Russel FG
    Eur J Pharm Sci; 2013 Aug; 49(5):819-28. PubMed ID: 23806476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of oat3-mediated renal uptake as a mechanism for drug-drug interaction between fexofenadine and probenecid.
    Tahara H; Kusuhara H; Maeda K; Koepsell H; Fuse E; Sugiyama Y
    Drug Metab Dispos; 2006 May; 34(5):743-7. PubMed ID: 16455804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dealing with the complex drug-drug interactions: towards mechanistic models.
    Varma MV; Pang KS; Isoherranen N; Zhao P
    Biopharm Drug Dispos; 2015 Mar; 36(2):71-92. PubMed ID: 25545151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitavastatin as an in vivo probe for studying hepatic organic anion transporting polypeptide-mediated drug-drug interactions in cynomolgus monkeys.
    Takahashi T; Ohtsuka T; Yoshikawa T; Tatekawa I; Uno Y; Utoh M; Yamazaki H; Kume T
    Drug Metab Dispos; 2013 Oct; 41(10):1875-82. PubMed ID: 23929936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition of human multidrug and toxin extrusion 1 is involved in the drug-drug interaction caused by cimetidine.
    Matsushima S; Maeda K; Inoue K; Ohta KY; Yuasa H; Kondo T; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2009 Mar; 37(3):555-9. PubMed ID: 19074525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions.
    Britz H; Hanke N; Taub ME; Wang T; Prasad B; Fernandez É; Stopfer P; Nock V; Lehr T
    Pharm Res; 2020 Nov; 37(12):250. PubMed ID: 33237382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of Transporter-Mediated Drug-Drug Interactions for Baricitinib.
    Posada MM; Cannady EA; Payne CD; Zhang X; Bacon JA; Pak YA; Higgins JW; Shahri N; Hall SD; Hillgren KM
    Clin Transl Sci; 2017 Nov; 10(6):509-519. PubMed ID: 28749581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of transporters in the disposition of a novel β-lactamase inhibitor: relebactam (MK-7655).
    Chan G; Houle R; Lin M; Yabut J; Cox K; Wu J; Chu X
    J Antimicrob Chemother; 2019 Jul; 74(7):1894-1903. PubMed ID: 30891606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin and cimetidine: Physiologically based pharmacokinetic modelling to investigate transporter mediated drug-drug interactions.
    Burt HJ; Neuhoff S; Almond L; Gaohua L; Harwood MD; Jamei M; Rostami-Hodjegan A; Tucker GT; Rowland-Yeo K
    Eur J Pharm Sci; 2016 Jun; 88():70-82. PubMed ID: 27019345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters.
    Tahara H; Kusuhara H; Endou H; Koepsell H; Imaoka T; Fuse E; Sugiyama Y
    J Pharmacol Exp Ther; 2005 Oct; 315(1):337-45. PubMed ID: 16006492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.